Why Your Body Destroys NAD+ Before It Can Use It (And the $5 Fix Nobody Talks About)

Your body cannot use NAD+ directly. The molecule is too large to cross a cell membrane, so when you take an NAD+ supplement, or receive it intravenously, your body breaks it down outside the cell into smaller pieces and then rebuilds it from scratch on the inside. A 2019 study tracking intravenous NAD+ infusions found that 750 milligrams administered over six hours was completely broken down in the bloodstream before any of it reached the interior of a cell. Every molecule was degraded extracellularly. None of it crossed the membrane intact.

That is the baseline reality. NAD+ itself is not the supplement. It is always the precursor.

So the supplement industry shifted to selling those precursors, specifically NMN and NR, which are smaller molecules that can actually get into the cell. The logic sounds clean: give your body the building blocks closer to the finished product and you save steps. And the logic is partially right. But there is a wrinkle most people selling these products do not explain clearly.

NMN cannot enter most cells directly either. A 2016 study established that NMN has to be converted to NR first, by an enzyme called CD73 sitting on the outside of the cell membrane, before it can be transported inside. So when you take NMN, your body converts it to NR, and then NR enters the cell. Which means NMN and NR supplements are doing essentially the same thing once they are in your body. They are both funneling into the same pathway.

That pathway is called the salvage pathway, which is the system your body uses to recycle NAD+ breakdown products back into usable NAD+. Think of it like a recycling plant. The plant takes whatever raw material comes in, processes it, and outputs finished NAD+. Both NMN and NR are feeding that same plant through the same entrance.

Now here is where age becomes the problem. There is an enzyme called CD38, and its job is essentially the opposite of NAD+ production. It degrades NAD+. And a 2016 study found that CD38 activity increases two to three fold across tissues as you age, with a near-perfect inverse correlation to NAD+ levels. As CD38 goes up, NAD+ comes down. The recycling plant is trying to keep up, but there is a machine in the same building that is shredding the output faster than the workers can produce it.

This is why people age into NAD+ deficiency even when eating well. It is not just that production slows. It is that a specific degradation enzyme accelerates, and the precursors most people are paying for go straight into the pathway that is already fighting that same headwind.

What most people have never heard of is the other pathway.

Your body has a completely separate route to building NAD+ that does not run through the salvage pathway at all. It is called the Preiss-Handler pathway, and the molecule that enters through it is niacin, which is just the plain form of vitamin B3. Not niacinamide, not NMN, not NR. Plain niacin. It enters through a different door entirely, bypasses the congested salvage pathway, and gets converted into NAD+ through a separate enzymatic chain.

A 2020 study in humans with confirmed NAD+ deficiency gave subjects niacin at doses ranging from 750 to 1000 milligrams per day. Blood NAD+ levels rose 2.3 times. Muscle NAD+ rose 1.3 times. Muscle strength improved. The researchers also observed signs of mitochondrial biogenesis, meaning the cells were building new mitochondria, which is one of the downstream effects people are hoping to get from NAD+ optimization in the first place.

That 2.3-fold increase in blood NAD+ puts niacin in the same range as what NMN and NR studies have reported, at a cost of roughly five dollars a month compared to thirty to eighty.

There is one practical consideration worth knowing before you go buy it. Niacin at these doses causes something called a niacin flush, where your skin turns red and warm, sometimes itchy, for twenty to thirty minutes after taking it. It happens because niacin triggers prostaglandin release, which dilates blood vessels near the skin surface. It is not dangerous. It is not an allergic reaction. It fades over the first one to two weeks of consistent use as your body adapts. Taking it with food and starting at a lower dose before working up reduces it significantly.

There is also an interesting footnote from a 2019 study on NR supplementation. When researchers looked at what was happening in human skeletal muscle after NR supplementation, they found significant increases in something called NAAD, which is an intermediate in the Preiss-Handler pathway, not the salvage pathway. The implication is that NR does not stay purely in the salvage pathway once it is inside the cell. Some of it converts to nicotinic acid and enters the Preiss-Handler route anyway. So even people taking NR may be getting some of their benefit through the pathway that niacin uses directly.

That finding is worth sitting with. Because if NR is partially working by converting into something niacin already is, then niacin is not the cheap workaround. It is the more direct path.

The idea that NAD+ supplementation requires expensive, proprietary molecules is built on a real biochemical foundation, because the salvage pathway is real, NMN and NR do raise NAD+, and the problem of age-related NAD+ decline is well-documented. None of that is wrong. What is incomplete is the idea that the salvage pathway is the only pathway, or that the most expensive molecule closest to NAD+ is automatically the most effective one.

Sometimes the molecule your body has been using for a century costs five dollars and enters through a door nobody is selling tickets to.

---

References

1. Ratajczak J, Joffraud M, Trammell SAJ, et al. 2016. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nature Communications, 7:13103. Finding: NMN must be converted to NR by CD73 before cellular uptake, establishing NR as the common entry point for both NMN and NR supplementation. Source
2. Elhassan YS, Kluckova K, Fletcher RS, et al. 2019. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Reports, 287:1717-1728. Finding: NR supplementation produced significant increases in NAAD a Preiss-Handler pathway intermediate in human muscle, indicating NR partially converts to nicotinic acid in vivo. Source
3. Pirinen E, Auranen M, Khan NA, et al. 2020. Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. Cell Metabolism, 316:1078-1090. Finding: Niacin 750-1000 mg/day raised blood NAD+ 2.3x and muscle NAD+ 1.3x in human subjects via the Preiss-Handler pathway, with concurrent improvements in muscle strength and mitochondrial biogenesis. Source
4. Grant R, Berg J, Mestayer R, et al. 2019. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Frontiers in Aging Neuroscience, 11:257. Finding: IV NAD+ 750 mg was rapidly and completely removed from plasma, with metabolites confirming full extracellular degradation before cellular uptake. Source
5. Camacho-Pereira J, Tarrago MG, Chini CCS, et al. 2016. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metabolism, 236:1127-1139. Finding: CD38 activity increases 2-3 fold with age across tissues, with near-perfect inverse correlation to NAD+ levels. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness